Mitral-Aortic Flow Reversal in Cardiac Resynchronization Therapy: Coupling With Ejection and Impact of Variations in Atrioventricular Delay
Sign Up to like & getrecommendations! Published in 2017 at "Circulation: Arrhythmia and Electrophysiology"
DOI: 10.1161/circep.116.004927
Abstract: Background— Flow entering the left ventricle is reversed toward the outflow tract through rotating reversal flow around the mitral valve. This was thought to facilitate early ejection, but had not been proved to date. We… read more here.
Keywords: ejection flow; ejection; reversal ejection; avd ... See more keywords
Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-154
Abstract: Background The most widely used prognostication tool in classical Hodgkin lymphoma (cHL) historically has been the International Prognostic Score (IPS), developed to predict survival at 5 years (yrs) in patients (pts) with newly diagnosed advanced-stage… read more here.
Keywords: trial; stage; performance; avd ... See more keywords
Incidence of severe chemotherapy-associated nausea and vomiting with brentuximab vedotin and AVD in comparison with ABVD using standard anti-emetic prophylaxis
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-4526
Abstract: Introduction: Chemotherapy-induced nausea and vomiting (CINV) remains an important side effect of chemotherapy for patients with classical Hodgkin's Lymphoma (cHL). The BV-AVD (brentuximab vedotin- doxorubicin, vinblastine, dacarbazine) regimen for cHL improves overall survival in advanced… read more here.
Keywords: group; abvd; avd; nausea ... See more keywords